Drug intelligence / Profile preview

Gracilaria salicornia extract

Development stage
Preclinical
Administration
Oral
01

Overview

Gracilaria salicornia extract is a botanical extract derived from the red macroalga *Gracilaria salicornia*, which is found in tropical marine environments such as the coast of North Sulawesi, Indonesia. It is primarily investigated for its potential antineoplastic and antioxidant properties. In preclinical research, ethanol extracts of this seaweed have demonstrated cytotoxic activity against human cervical adenocarcinoma (HeLa) cells, although it often shows lower potency compared to other tropical seaweeds like *Turbinaria decurrens*. Its mechanism of action is thought to involve bioactive secondary metabolites, including phenolic compounds, which contribute to antioxidant activity by scavenging reactive oxygen species (ROS) and reducing oxidative stress. While it exhibits antiproliferative effects in vitro, it is currently in the early research stage and is not an approved pharmaceutical.

Other names
Gracilaria salicornia ethanol extract
02

Targets

HYAL (Hyaluronidase family (HYAL))

Beyond the preview

Go deeper on Gracilaria salicornia extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gracilaria salicornia extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call